Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function.
Activation of lymphocytes is a complex, yet finely regulated cascade of events that results in the expression of cytokine receptors, production and secretion of cytokines and expression of several cell surface molecules that eventually lead to divergent immune responses. Assessing the qualitative and quantitative nature of lymphocyte function following immunotherapy provides valuable information about the immune responses mediated by a therapeutic agent. To facilitate evaluation of the immunomodulatory activity of therapeutic agents, we have established a platform of in vitro immunoassays with normal human peripheral blood mononuclear cells (PBMCs) treated with several polyclonal activators that are known to exhibit different modes of action. We evaluated the kinetics of cell surface marker expression and cytokine release from PBMCs stimulated in parallel with various activating agents over a time course. These stimulating agents induced early (CD69 and CD71) and late (CD25 and HLA-DR) activation markers to varying antigen densities, indicated different cytokine profiles, and showed differential inhibition with dexamethasone (DEX), an inhibitor of early signaling events. Based on the association or correlation of the kinetics of activation marker expression and secreted cytokines, the results of our study indicate the appropriate time points for the simultaneous measurement of both these activation products. This study defines the kinetics for both measures of T cell activation and provides a comprehensive review with various polyclonal activators that can serve as a reference for monitoring lymphocyte function in clinical study samples.
Reddy
Manjula
M
Department of Clinical Pharmacology, Centocor, 145 King of Prussia Road, Radnor, PA 19087-4517, USA.
Eirikis
Edward
E
Davis
Cuc
C
Davis
Hugh M
HM
Prabhakar
Uma
U
D000906:Antibodies / Q000276:immunology; D015415:Biomarkers; D018106:CD28 Antigens / Q000276:immunology; D017252:CD3 Complex / Q000276:immunology; D016207:Cytokines / Q000378:metabolism*; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*; D066298:In Vitro Techniques; D015759:Ionomycin / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D007700:Kinetics; D008213:Lymphocyte Activation / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology* / Q000378:metabolism; D018448:Models, Immunological; D010835:Phytohemagglutinins / Q000494:pharmacology; D018089:Superantigens / Q000276:immunology; D013997:Time Factors
D000906:Antibodies; D015415:Biomarkers; D018106:CD28 Antigens; D017252:CD3 Complex; D016207:Cytokines; D007476:Ionophores; D010835:Phytohemagglutinins; D018089:Superantigens; C028784:phytohemagglutinin-P; D015759:Ionomycin